• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4695755)   Today's Articles (200)
For: Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Genève J, Lasser P, Rougier P. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial. J Clin Oncol 2011;29:1715-21. [PMID: 21444866 DOI: 10.1200/jco.2010.33.0597] [Citation(s) in RCA: 1467] [Impact Index Per Article: 104.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]  Open
Number Cited by Other Article(s)
1
Weng CM, Zhong Q, Sun YQ, Liu ZY, Ma YB, Zhang ZQ, Zhang HX, Zhu JY, Ye W, Wu J, Du H, Zheng CH, Li P, Chen QY, Huang CM, Xie JW. A novel ypN-TRG staging system for gastric cancer patients after neoadjuvant therapy based on the metro-ticket paradigm: a multicenter and large sample retrospective analysis. Gastric Cancer 2025;28:465-477. [PMID: 39918688 DOI: 10.1007/s10120-025-01586-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2024] [Accepted: 01/15/2025] [Indexed: 03/03/2025]
2
Wang XD, Su XQ, Gao H. Association of Sijunzi decoction plus chemotherapy with gastrointestinal function and serum markers in patients after gastric carcinoma surgery. World J Gastrointest Surg 2025;17:100800. [DOI: 10.4240/wjgs.v17.i4.100800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/20/2024] [Revised: 01/24/2025] [Accepted: 02/25/2025] [Indexed: 03/29/2025]  Open
3
Lu YM, Ye ZB, Wang HK, Zhong WH, Shao XX, Hu HT, Jiang YJ, Li WY, Tian YT. Comparative outcomes of laparoscopic and open gastrectomy for T4b gastric cancer with transverse colon or mesentery invasion: a dual-center retrospective analysis. World J Surg Oncol 2025;23:150. [PMID: 40259398 PMCID: PMC12012946 DOI: 10.1186/s12957-025-03809-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2025] [Accepted: 04/13/2025] [Indexed: 04/23/2025]  Open
4
Miura T, Yashima T, Takaya E, Taniyama Y, Sato C, Okamoto H, Ozawa Y, Ishida H, Unno M, Ueda T, Kamei T. Multimodal deep-learning model using pre-treatment endoscopic images and clinical information to predict efficacy of neoadjuvant chemotherapy in esophageal squamous cell carcinoma. Esophagus 2025;22:207-214. [PMID: 39792350 DOI: 10.1007/s10388-025-01106-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Accepted: 01/05/2025] [Indexed: 01/12/2025]
5
Liu B, Shen C, Yin X, Jiang T, Han Y, Yuan R, Yin Y, Cai Z, Zhang B. Perioperative chemotherapy for gastric cancer patients with microsatellite instability or deficient mismatch repair: A systematic review and meta-analysis. Cancer 2025;131:e35831. [PMID: 40159317 DOI: 10.1002/cncr.35831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2024] [Revised: 11/28/2024] [Accepted: 02/17/2025] [Indexed: 04/02/2025]
6
Liu DS, Lee MM, Hall K, Watson DI, Ferri L, So J, Donohoe CL, Michael M, Tebbutt NC, Wong DJ, Duong CP, Bright T, Aly A, Gill S, Cheng C, Goh SK, Read M, Tan J, Stevens S, Wong E, Ooi G, Lam YH, Lee E, Williams D, Jackett L, Chan K, Smith G, Chan DL, Merrett N, Gananadha S, Kanhere H, Kennedy L, Smithers M, Thomas J, Bozin M, Chong L, Mori K, Johnson MA, Martin SA, Usatoff V, Jacobs R, Al-Habbal Y, Liew CH, Huynh F, Bohmer R, Pande G, Daruwalla J, Ballal M, Lee D, Ranjan R, MacCormick AD, Wilkins J, Pattison S, Evennett N, Wilkins J, Robertson J, Pang M, Gordon A, Bann S, Lim YK, Samarasam I, Gurunathan R, Yeung J, Allison F, Siblini A, Griffiths EA, Phillips AW, Prasad P, Markar S, Chidambaram S, Chan D, Murphy T, Reynolds J, Nilsson M, Klevebro F, Piessen G, Lerooy J, Wijnhoven B, van der Zijden C, van Hillegersberg R, Triemstra L, Ruurda J, van Berge Henegouwen MI, Gisbertz SS, Lombardi PM, Edmondson A, Wei JQ, Lorenzo A, Alhayo S, Narendra A, Rahim A, Ho R, Granger J, Tran S, Koullouros M, Nguyen A, McVeay C, Gan SW, Hopping E, Thomson I, et alLiu DS, Lee MM, Hall K, Watson DI, Ferri L, So J, Donohoe CL, Michael M, Tebbutt NC, Wong DJ, Duong CP, Bright T, Aly A, Gill S, Cheng C, Goh SK, Read M, Tan J, Stevens S, Wong E, Ooi G, Lam YH, Lee E, Williams D, Jackett L, Chan K, Smith G, Chan DL, Merrett N, Gananadha S, Kanhere H, Kennedy L, Smithers M, Thomas J, Bozin M, Chong L, Mori K, Johnson MA, Martin SA, Usatoff V, Jacobs R, Al-Habbal Y, Liew CH, Huynh F, Bohmer R, Pande G, Daruwalla J, Ballal M, Lee D, Ranjan R, MacCormick AD, Wilkins J, Pattison S, Evennett N, Wilkins J, Robertson J, Pang M, Gordon A, Bann S, Lim YK, Samarasam I, Gurunathan R, Yeung J, Allison F, Siblini A, Griffiths EA, Phillips AW, Prasad P, Markar S, Chidambaram S, Chan D, Murphy T, Reynolds J, Nilsson M, Klevebro F, Piessen G, Lerooy J, Wijnhoven B, van der Zijden C, van Hillegersberg R, Triemstra L, Ruurda J, van Berge Henegouwen MI, Gisbertz SS, Lombardi PM, Edmondson A, Wei JQ, Lorenzo A, Alhayo S, Narendra A, Rahim A, Ho R, Granger J, Tran S, Koullouros M, Nguyen A, McVeay C, Gan SW, Hopping E, Thomson I, Barbour A, Gotley D, Frankel A, Patel R, Chew SJH, Lah K, Gill S, Barnett SA, Muralidharan V, Phillips S, Jamel W, Ko BK, Joglekar S, Rajagopalan A, Jaya J, Chung YC, Peeroo S, Bak M, Tiong J, Zhou Z, Crowe A, Newbold R, Trainor B, Pac Soo ML, Khandelwal V, Eikelboom N, Kim K, Moran E, Hammerschlag J, Desmond B, D'Souza J, Lu J, McLay-Barnes R, Gower A, Choi J, Lim YK, Wood D, Whytock K, Surendran S, Paul N, Khan H F, Chia DKA, Leong EKF, Ijner T, Lin YTL, Liew MS, Jaretzke H, Dempster N, Bhanot K, Mian A, Mastoridis S, Gibbons B, Owen-Smith S, Walmsley J, Al Azzawi M, Doyle E, Okamura Y, Keywani K, Ferrari G, Gualtierotti M, De Martini P, Bushati F. Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study. Br J Surg 2025;112:znaf056. [PMID: 40156891 DOI: 10.1093/bjs/znaf056] [Show More Authors] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2024] [Revised: 02/11/2025] [Accepted: 02/20/2025] [Indexed: 04/01/2025]
7
Pu W, Li S, Zhang J, Huang J, Li J, Jiang Y, Xu Z, Yi F, Lan Y, Xiao Q, Chen W, Jin J. The efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials. Front Immunol 2025;16:1566939. [PMID: 40207218 PMCID: PMC11979168 DOI: 10.3389/fimmu.2025.1566939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2025] [Accepted: 03/11/2025] [Indexed: 04/11/2025]  Open
8
Lin Y, Lan Y, Zheng Y, Ma M. Dual-energy CT for evaluating the tumor regression grade of gastric cancer after neoadjuvant chemotherapy. Eur Radiol 2025:10.1007/s00330-025-11508-1. [PMID: 40100398 DOI: 10.1007/s00330-025-11508-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Revised: 01/19/2025] [Accepted: 02/14/2025] [Indexed: 03/20/2025]
9
Li TH, Sun X, Li CG, Yin YP, Tao KX. Hypercoagulation after neoadjuvant immunochemotherapy as a new prognostic indicator in patients with locally advanced gastric cancer undergoing surgery. World J Gastrointest Oncol 2025;17:100927. [PMID: 40092957 PMCID: PMC11866221 DOI: 10.4251/wjgo.v17.i3.100927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2024] [Revised: 12/06/2024] [Accepted: 12/25/2024] [Indexed: 02/14/2025]  Open
10
Yu X, Cui R, Guo P. Evaluation of the efficacy and safety of toripalimab combination therapy for treatment of advanced gastric cancer: a meta-analysis. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 2025;18:96-109. [PMID: 40226111 PMCID: PMC11982770 DOI: 10.62347/gzow5960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2024] [Accepted: 02/12/2025] [Indexed: 04/15/2025]
11
Ou H, Zhuang J, Jian M, Zheng X, Wu T, Cheng H, Qian R. Perioperative versus adjuvant chemotherapy for resectable gastric cancer: a meta-analysis of randomized controlled trials. Front Oncol 2025;15:1432596. [PMID: 40115020 PMCID: PMC11922704 DOI: 10.3389/fonc.2025.1432596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Accepted: 02/17/2025] [Indexed: 03/22/2025]  Open
12
Gan X, Jia Y, Shan F, Ying X, Li S, Zhang Y, Pang F, Li Z. Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial. BMC Cancer 2025;25:401. [PMID: 40045265 PMCID: PMC11884205 DOI: 10.1186/s12885-024-13372-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2024] [Accepted: 12/19/2024] [Indexed: 03/09/2025]  Open
13
Jiang W, Zhang B, Xu J, Xue L, Wang L. Current status and perspectives of esophageal cancer: a comprehensive review. Cancer Commun (Lond) 2025;45:281-331. [PMID: 39723635 PMCID: PMC11947622 DOI: 10.1002/cac2.12645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2024] [Revised: 12/08/2024] [Accepted: 12/10/2024] [Indexed: 12/28/2024]  Open
14
He J, Zhang B, Zhou S, Yang Y, Han Z, Wu T, Qiao Q, Yang H, He X, Wang N. Phase II study of perioperative camrelizumab and XELOX for locally advanced gastric or gastroesophageal junction adenocarcinoma. Cancer Sci 2025;116:736-743. [PMID: 39656600 PMCID: PMC11875781 DOI: 10.1111/cas.16425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2024] [Revised: 11/15/2024] [Accepted: 11/24/2024] [Indexed: 12/17/2024]  Open
15
Malekzada F, Vladimiriov M, Leitz M, Michel J, Nimzewski F, Hoeppner J. Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy. Innov Surg Sci 2025;10:3-9. [PMID: 40144785 PMCID: PMC11934940 DOI: 10.1515/iss-2023-0005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Accepted: 10/07/2024] [Indexed: 03/28/2025]  Open
16
Dehal A, Woo Y, Glazer ES, Davis JL, Strong VE. D2 Lymphadenectomy for Gastric Cancer: Advancements and Technical Considerations. Ann Surg Oncol 2025;32:2129-2140. [PMID: 39589578 DOI: 10.1245/s10434-024-16545-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2024] [Accepted: 11/05/2024] [Indexed: 11/27/2024]
17
Wu T, Zhou J, He W, Jin L, Li T, Gong T, Liu X. An injectable multimodal thiolated carboxymethyl cellulose hydrogel for advanced gastric cancer treatment. Int J Biol Macromol 2025;306:141546. [PMID: 40020807 DOI: 10.1016/j.ijbiomac.2025.141546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2024] [Revised: 02/14/2025] [Accepted: 02/25/2025] [Indexed: 03/03/2025]
18
Xu G, Liu T, Shen J, Guan Q. Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs . chemotherapy alone in HER2(-) locally advanced gastric cancer: A propensity score-matched cohort study. Chin Med J (Engl) 2025;138:459-471. [PMID: 38420853 PMCID: PMC11845188 DOI: 10.1097/cm9.0000000000003028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Indexed: 03/02/2024]  Open
19
Serra F, Valerio F, Pedrazzoli P, Viganò J, Caccialanza R, Cicognini D, Pagani A, Corallo S. Real-life effectiveness of FLOT in resectable gastric cancer: existing challenges. Drugs Context 2025;14:2024-10-7. [PMID: 40017727 PMCID: PMC11867168 DOI: 10.7573/dic.2024-10-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2024] [Accepted: 12/27/2024] [Indexed: 03/01/2025]  Open
20
Geng Y, Zhao J, Li Y, Li Y. Adjuvant treatment after neoadjuvant chemoradiotherapy and surgery in patients with esophageal squamous cell carcinoma: a real-world study. Ther Adv Med Oncol 2025;17:17588359251316179. [PMID: 39957805 PMCID: PMC11829303 DOI: 10.1177/17588359251316179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2024] [Accepted: 01/09/2025] [Indexed: 02/18/2025]  Open
21
Jang T, Kim GP, George TJ. Select updates from ASCO and ESMO 2024 for gastrointestinal cancer care. Oncologist 2025;30:oyaf020. [PMID: 39998903 PMCID: PMC11853594 DOI: 10.1093/oncolo/oyaf020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2024] [Accepted: 01/16/2025] [Indexed: 02/27/2025]  Open
22
Sugiyama K, Gordon A, Popat S, Okines A, Larkin J, Chau I. Is pathological response an adequate surrogate marker for survival in neoadjuvant therapy with immune checkpoint inhibitors? ESMO Open 2025;10:104122. [PMID: 39874902 PMCID: PMC11808614 DOI: 10.1016/j.esmoop.2024.104122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2024] [Revised: 12/17/2024] [Accepted: 12/18/2024] [Indexed: 01/30/2025]  Open
23
Su F, Huang X, Yin J, Tang H, Tan L, Shen Y. Nodal Downstaging of Esophageal Cancer After Neoadjuvant Therapy: A Cohort Study and Meta-Analysis. Cancer Med 2025;14:e70664. [PMID: 39918200 PMCID: PMC11803740 DOI: 10.1002/cam4.70664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2024] [Revised: 12/08/2024] [Accepted: 01/28/2025] [Indexed: 02/11/2025]  Open
24
Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Lordick Obermannová R, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Buges Sanchez C, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B, van Grieken NCT, Nilsson M, Collienne M, Giraut A, Smyth E. Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study. Ann Oncol 2025;36:197-207. [PMID: 39542422 DOI: 10.1016/j.annonc.2024.10.829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2024] [Revised: 10/31/2024] [Accepted: 10/31/2024] [Indexed: 11/17/2024]  Open
25
Waller GC, Khan TM, Correa-Gallego C. Minimally Invasive Gastrectomy. Surg Clin North Am 2025;105:15-30. [PMID: 39523070 DOI: 10.1016/j.suc.2024.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2024]
26
Li C, Tian Y, Zheng Y, Yuan F, Shi Z, Yang L, Chen H, Jiang L, Wang X, Zhao P, Zhang B, Wang Z, Zhao Q, Dong J, Lian C, Xu S, Zhang A, Zheng Z, Wang K, Dang C, Wu D, Chen J, Xue Y, Liang B, Cheng X, Wang Q, Chen L, Xia T, Liu H, Xu D, Zhuang J, Wu T, Zhao X, Wu W, Wang H, Peng J, Hou Z, Zheng R, Chen Y, Yin K, Zhu Z. Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05). J Clin Oncol 2025;43:464-474. [PMID: 39383487 PMCID: PMC11776878 DOI: 10.1200/jco.24.00795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2024] [Revised: 08/01/2024] [Accepted: 09/05/2024] [Indexed: 10/11/2024]  Open
27
Srikumar T, Sundar R. Multimodality Treatment for Locally Advanced Gastric Adenocarcinoma. Surg Clin North Am 2025;105:75-94. [PMID: 39523078 DOI: 10.1016/j.suc.2024.06.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2024]
28
Jung JO, Bruns C. [Multimorbid patients in visceral surgery-Upper gastrointestinal tract]. CHIRURGIE (HEIDELBERG, GERMANY) 2025;96:89-94. [PMID: 39774998 DOI: 10.1007/s00104-024-02221-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 12/03/2024] [Indexed: 01/11/2025]
29
Bacoeur-Ouzillou O, Voron T, Lambert C, Fuks D, Piessen G, Manceau G, Guiramand J, Pezet D, Gronnier C, Gagnière J. Impact of obesity on outcomes following surgery for gastric adenocarcinoma: A European multi-institutional study. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2025;51:109518. [PMID: 39647445 DOI: 10.1016/j.ejso.2024.109518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2024] [Revised: 11/20/2024] [Accepted: 12/04/2024] [Indexed: 12/10/2024]
30
Sun X, Li X, Zhao S, Li C, Lin Y, Shen Q, Ding J, Li T, Yin Y, Tao K. Which surrogate endpoint best predict survival in locally advanced gastric cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery? A multicenter retrospective study. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2025;51:109517. [PMID: 39662107 DOI: 10.1016/j.ejso.2024.109517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2024] [Revised: 11/18/2024] [Accepted: 12/04/2024] [Indexed: 12/13/2024]
31
Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, Izbicki JR, Gockel I, Gerdes B, Ghadimi M, Reichert B, Lock JF, Bruns C, Reitsamer E, Schmeding M, Benedix F, Keck T, Folprecht G, Thuss-Patience P, Neumann UP, Pascher A, Imhof D, Daum S, Strieder T, Krautz C, Zimmermann S, Werner J, Mahlberg R, Illerhaus G, Grimminger P, Lordick F. Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer. N Engl J Med 2025;392:323-335. [PMID: 39842010 DOI: 10.1056/nejmoa2409408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2025]
32
Sabbagh S, Jabbal IS, Herrán M, Mohanna M, Iska S, Itani M, Dominguez B, Sarna K, Nahleh Z, Nagarajan A. Evaluating survival outcomes and treatment recommendations in resectable gastric cancer. Sci Rep 2025;15:2816. [PMID: 39843914 PMCID: PMC11754744 DOI: 10.1038/s41598-024-82807-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2024] [Accepted: 12/09/2024] [Indexed: 01/24/2025]  Open
33
Chen Y, He J, Zheng J, Lin Y, Wang H, Lian L, Peng J. Impact of pathological complete response on survival in gastric cancer after neoadjuvant chemotherapy: a propensity score matching analysis. BMC Gastroenterol 2025;25:11. [PMID: 39789426 PMCID: PMC11720295 DOI: 10.1186/s12876-025-03594-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2024] [Accepted: 01/06/2025] [Indexed: 01/12/2025]  Open
34
Song Y, Liu S, Liu X, Jia H, Shi H, Liu X, Hao D, Wang H, Xing X. An Integrated Radiopathomics Machine Learning Model to Predict Pathological Response to Preoperative Chemotherapy in Gastric Cancer. Acad Radiol 2025;32:134-145. [PMID: 39214816 DOI: 10.1016/j.acra.2024.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2024] [Revised: 08/06/2024] [Accepted: 08/08/2024] [Indexed: 09/04/2024]
35
Nomura M, Yamaguchi T, Chin K, Hato S, Kato K, Baba E, Matsubara H, Mukaida H, Yoshii T, Tsuda M, Tsubosa Y, Kitagawa Y, Oze I, Ishikawa H, Muto M. Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial. Ann Surg Oncol 2025;32:302-311. [PMID: 39375260 DOI: 10.1245/s10434-024-16325-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2024] [Accepted: 09/24/2024] [Indexed: 10/09/2024]
36
Koo A, Mavani PT, Sok C, Goyal S, Concors S, Mason MC, Winer JH, Russell MC, Cardona K, Lin E, Maithel SK, Kooby DA, Staley CA, Shah MM. Effect of Minimally Invasive Gastrectomy on Return to Intended Oncologic Therapy for Gastric Cancer. Ann Surg Oncol 2025;32:230-239. [PMID: 39516415 DOI: 10.1245/s10434-024-16440-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2024] [Accepted: 10/18/2024] [Indexed: 11/16/2024]
37
Waters J, Sewell M, Molena D. Multimodal Treatment of Resectable Esophageal Cancer. Ann Thorac Surg 2025;119:70-82. [PMID: 38777248 PMCID: PMC11579246 DOI: 10.1016/j.athoracsur.2024.04.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 03/20/2024] [Accepted: 04/22/2024] [Indexed: 05/25/2024]
38
Toyota K, Tanabe K, Kano M, Komo T, Hotta R, Yanagawa S, Saeki Y, Tazawa H, Ikeda M, Shishida M, Okano K, Ide R, Imaoka Y, Takahashi S, Ohdan H. Predictors of tolerability for postoperative adjuvant S1 plus docetaxel chemotherapy for gastric cancer: a multicenter retrospective study. Gastric Cancer 2025;28:102-111. [PMID: 39520590 PMCID: PMC11706876 DOI: 10.1007/s10120-024-01563-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2024] [Accepted: 10/11/2024] [Indexed: 11/16/2024]
39
Chang C, Cai Z, Cheng K, Shen C, Zhang B, Chen Z, Yin Y, Cao D. Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial. Updates Surg 2025;77:165-174. [PMID: 39738886 DOI: 10.1007/s13304-024-02052-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2023] [Accepted: 11/27/2024] [Indexed: 01/02/2025]
40
Jindani R, Rodriguez-Quintero JH, Loh I, Ha G, Olivera J, Rosario J, Zhu R, Kamel MK, Vimolratana M, Chudgar NP, Stiles BM. Do socioeconomic factors impair uptake of neoadjuvant therapy for patients with locoregional oesophageal cancer? Eur J Cardiothorac Surg 2024;67:ezae462. [PMID: 39798126 PMCID: PMC11739619 DOI: 10.1093/ejcts/ezae462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/10/2024] [Revised: 11/22/2024] [Accepted: 01/10/2025] [Indexed: 01/15/2025]  Open
41
He KJ, Gong G. Prognostic prediction and immune infiltration analysis based on lysosome and senescence state identifies MMP12 as a novel therapy target in gastric cancer. Int Immunopharmacol 2024;143:113344. [PMID: 39401475 DOI: 10.1016/j.intimp.2024.113344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2024] [Revised: 09/21/2024] [Accepted: 10/04/2024] [Indexed: 10/30/2024]
42
Norén N, Rouvelas I, Lundell L, Nilsson M, Sunde B, Szabo E, Edholm D, Hedberg J, Smedh U, Hermansson M, Lindblad M, Klevebro F. Curative treatment for oligometastatic gastroesophageal cancer- results of a prospective multicenter study. Langenbecks Arch Surg 2024;410:10. [PMID: 39680192 DOI: 10.1007/s00423-024-03575-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2024] [Accepted: 12/09/2024] [Indexed: 12/17/2024]
43
Ji Z, Wang X, Xin J, Ma L, Zuo D, Li H, Su L, Lv X, Ge S, Zhang L, Liu Y, Zhang Y, Ding T, Deng T, Ba Y, Liu R. Multiomics reveals tumor microenvironment remodeling in locally advanced gastric and gastroesophageal junction cancer following neoadjuvant immunotherapy and chemotherapy. J Immunother Cancer 2024;12:e010041. [PMID: 39653554 PMCID: PMC11629098 DOI: 10.1136/jitc-2024-010041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Accepted: 11/05/2024] [Indexed: 12/12/2024]  Open
44
Abyaneh R, Ghalehtaki R, Sanford NN. Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review. Cancer 2024;130:4040-4051. [PMID: 39297403 DOI: 10.1002/cncr.35561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2024] [Revised: 07/17/2024] [Accepted: 08/06/2024] [Indexed: 11/10/2024]
45
Costa M, Lopes Fernandes C, Magalhães H. Perioperative Treatment in Gastric Cancer: A Fast-Changing Field. Cancers (Basel) 2024;16:4036. [PMID: 39682222 DOI: 10.3390/cancers16234036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2024] [Revised: 11/21/2024] [Accepted: 11/27/2024] [Indexed: 12/18/2024]  Open
46
Nath J, Nath J, Kalita AK, Bhattacharyya M, Yanthan Y, Das J. Debating the Optimal Preoperative Approach: NACRT vs NACT in Locally Advanced Oesophageal Cancer. Indian J Surg Oncol 2024;15:573-580. [PMID: 39995543 PMCID: PMC11846798 DOI: 10.1007/s13193-024-02073-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Accepted: 08/14/2024] [Indexed: 02/26/2025]  Open
47
Jia W, Li C, Liu C, Hu R. Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: A retrospective cohort study. PLoS One 2024;19:e0304937. [PMID: 39561158 PMCID: PMC11575812 DOI: 10.1371/journal.pone.0304937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Accepted: 11/05/2024] [Indexed: 11/21/2024]  Open
48
Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. Oesophageal cancer. Lancet 2024;404:1991-2005. [PMID: 39550174 DOI: 10.1016/s0140-6736(24)02226-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/21/2024] [Revised: 09/16/2024] [Accepted: 10/07/2024] [Indexed: 11/18/2024]
49
Kelly NJ, Shafique N, Tortorello GN, Vargas G, Miura JT, Karakousis GC. Total Gastrectomy for Gastric Malignancy: Trends Over 15 Years in Major Morbidity, Mortality, and Patient Selection From The National Surgical Quality Improvement Program. J Surg Oncol 2024. [PMID: 39539107 DOI: 10.1002/jso.27990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2024] [Accepted: 10/12/2024] [Indexed: 11/16/2024]
50
Skjoldbirk J, Egebjerg K, Qvortrup C, Lund CM, Bæksgaard L, Achiam MP, Mau-Sørensen M. Dose reduced preoperative chemotherapy in older patients with resectable gastroesophageal cancer: A real-world data study. J Geriatr Oncol 2024;15:102072. [PMID: 39321688 DOI: 10.1016/j.jgo.2024.102072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2024] [Revised: 09/07/2024] [Accepted: 09/17/2024] [Indexed: 09/27/2024]
PrevPage 1 of 30 123452930Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Excel